Aboriginal and Torres Strait Islander people aged 2 months to 19 years are strongly recommended to receive MenACWY vaccine.
The dose schedule for MenACWY vaccine depends on the vaccine brand and the person’s age when they start the vaccine course.
Infants aged <9 months can receive 2 of the 3 MenACWY brands (Menveo or Nimenrix).
Infants and children aged 9 months to 2 years can receive any of the 3 MenACWY vaccine brands, following the age-appropriate dosing schedule.
For all people aged ≥2 years, a single dose of MenACWY vaccine is recommended. In this age group, it is preferable to receive either Menveo or Nimenrix, rather than Menactra. If Menveo and Nimenrix are unavailable, Menactra can be given.
The Department of Health acknowledges the traditional owners of country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to elders both past and present.